Target intelligence / Profile preview

Remodeling and spacing factor 1 (RSF1)

Target
RSF1
Molecular classification
Chromatin remodeling factor, Epigenetic regulator, Protein complex subunit (RSF complex), Other
01

Overview

Remodeling and spacing factor 1 (RSF1) is a key chromatin remodeling factor that functions primarily as part of the RSF complex, in association with the SNF2H ATPase, to regulate nucleosome spacing and chromatin structure[2][3]. RSF1 is involved in transcriptional repression, acting as a reader for histone H2A ubiquitination (H2Aub), and directly participates in polycomb-mediated gene silencing and chromatin compaction[3]. It plays crucial roles in the DNA damage response, facilitating both homologous recombination and non-homologous end joining by recruiting repair factors such as XRCC4 and interacting with mitotic kinases and histone modifiers like HDAC1[1][4][6]. RSF1 controls centromere function, ensuring proper chromosome alignment and segregation during mitosis[6]. Overexpression of RSF1 is observed in multiple tumor types, implicating it in cancer progression and chemoresistance, while also modulating cell cycle regulators and inflammatory responses through interactions with non-coding RNAs and transcription factor networks[1][2].

Other names
RSF1HBXAPXAP8Rsf-1p325HBV pX-associated protein 8Hepatitis B virus X-associated proteinp325 subunit of RSF chromatin-remodeling complex
02

Mechanism of action

Not directly a drug target; however, mechanistically, RSF1 modulates DNA repair and transcription via interaction with histone-modifying enzymes (e.g., HDAC1) and by reading H2Aub marks[3][4].

03

Biological functions

Chromatin remodelingDNA double-strand break repair (homologous recombination and non-homologous end joining)Regulation of gene expression (transcriptional control and gene silencing)Cell cycle progression and mitosis (chromosome alignment and segregation)Maintenance of genome integrity
04

Disease associations

Cancer (oncogenic overexpression, role in tumorigenesis and genome instability)ChemoresistanceOther (possible role in inflammation)
05

Safety considerations

Not established as a direct therapeutic target; concerns would relate to off-target effects on chromatin integrity and genome stability if targeted.
06

Biomarkers

Overexpression in tumors can be used as a potential biomarker for cancer prognosis or therapeutic stratification[1].

Beyond the preview

Go deeper on Remodeling and spacing factor 1 (RSF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Remodeling and spacing factor 1 (RSF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call